First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Clinical trial NCT07586618 · RECRUITING
Trial details
- NCT number
- NCT07586618
- Sponsor
- Allterum Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.